
Indraprastha Medical Corporation Ltd Faces Bearish Momentum Amid Technical Downgrade
2026-05-19 08:00:25Indraprastha Medical Corporation Ltd, a small-cap player in the hospital sector, has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a more pronounced bearish trend. This transition is underscored by a series of technical indicators signalling weakening price momentum, with the stock currently trading at ₹360.05, down 2.15% from its previous close of ₹367.95.
Read MoreAre Indraprastha Medical Corporation Ltd latest results good or bad?
2026-05-13 19:17:01Indraprastha Medical Corporation Ltd's latest financial results for Q4 FY26 reveal a complex operational landscape. The company reported a net profit of ₹41.70 crores, reflecting a year-on-year growth of 1.68%, which is a notable decline from the previous year's growth rate of 31.57%. Revenue for the quarter reached ₹364.81 crores, marking a year-on-year increase of 9.31%, which is an improvement compared to the 6.04% growth seen in Q4 FY25. However, the results also highlight significant challenges, particularly in terms of operational efficiency. The operating margin, excluding other income, fell to 16.59%, the lowest level in eight quarters, indicating a contraction from 18.37% in the same quarter last year. This margin compression raises concerns about the sustainability of profitability, as it suggests potential issues with cost management or pricing power in a competitive market. The company's total...
Read More
Indraprastha Medical Corporation Ltd is Rated Sell
2026-05-12 10:10:46Indraprastha Medical Corporation Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 30 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 12 May 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook.
Read More
Indraprastha Medical Corporation Ltd is Rated Sell
2026-04-20 10:10:48Indraprastha Medical Corporation Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 30 January 2026. However, all fundamentals, returns, and financial metrics discussed here reflect the stock's current position as of 20 April 2026, providing investors with an up-to-date analysis of the company’s standing.
Read More
Indraprastha Medical Corporation Ltd is Rated Sell
2026-04-09 10:10:32Indraprastha Medical Corporation Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 30 January 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 09 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.
Read MoreIndraprastha Medical Corporation Ltd Gains 4.07%: Key Momentum Shifts and Market Dynamics
2026-04-05 17:00:03Key Events This Week 30 Mar: Bearish momentum and technical downgrade weigh on stock (Rs.371.65, -3.43%) 1 Apr: Strong gap up and intraday high with 7.48% surge (Rs.398.90) 2 Apr: Modest gain continues, closing at Rs.400.50 (+0.40%) Week Close: Rs.400.50, overall +4.07% vs Sensex -0.29% Week OpenRs.384.85 Week Close<d...
Read More
Indraprastha Medical Corporation Ltd Surges 7.48% to Day's High of Rs 396.05 — Outperforms Sector by 6.8 Percentage Points
2026-04-01 11:30:54The Sensex declined by 2.18% on 1 Apr 2026, yet Indraprastha Medical Corporation Ltd surged 7.48%, outperforming its Hospital sector by 6.8 percentage points. This sharp single-session gain rewrites the short-term narrative for the small-cap stock, raising the question of whether this is a genuine recovery or a technical bounce within a broader downtrend.
Read More
Indraprastha Medical Corporation Ltd Faces Bearish Momentum Amid Technical Downgrade
2026-03-30 08:00:07Indraprastha Medical Corporation Ltd, a small-cap player in the hospital sector, has experienced a notable shift in its technical momentum, prompting a downgrade in its MarketsMOJO grade from Hold to Sell as of 30 January 2026. The stock’s recent price action and technical indicators signal a bearish trend, reflecting growing investor caution amid broader market pressures and sector-specific challenges.
Read MoreAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
02-Jun-2026 | Source : BSEWe wishh to inform you that the management of the company intends to engage in discussions with investors/analyst meet on 4th June 2026 & 5th June 2026 at Mumbai. Further please note that no unpublished price sensitive information pertaning to the company will be shared at aforesaid meet.
Announcement under Regulation 30 (LODR)-Credit Rating
27-May-2026 | Source : BSEwe wish to inform you that ICRA Limited has vide its letter dated 26th May 2026 re-affirmed its rating on the long term bank facility and instrumnet of Indraprasth Medical Corporation Limited at [ICRA]AA(Stable) and the short term rating at [ICRA]A1+.
Board Meeting Outcome for OUTCOME OF THE BOARD MEETING
12-May-2026 | Source : BSEthe board of directors of the company inter-alia : 1. Approved the audited finacial results for the quater/year ended 31st March 2026 2. Reccomended a dividend @ 40% i.e. Rs 4 per equity shares for the finacial year 2025-2026 subject to approval of shareholders at the AGM of the company.
Corporate Actions
No Upcoming Board Meetings
Indraprastha Medical Corporation Ltd has declared 45% dividend, ex-date: 18 Sep 25
No Splits history available
No Bonus history available
No Rights history available
